We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Biogen Idec and Alnylam Pharmaceuticals, Inc. announced a collaboration to discover and develop RNAi therapeutics for the potential treatment of progressive multifocal leukoencephalopathy (PML).
German chemical and pharmaceutical company Altana AG said Thursday it was selling its drugs business to Denmark's Nycomed for euro 4.5 billion, following through on its intention to split the company in two and focus on its chemicals arm.
German drugmaker Merck KGaA on Thursday agreed to buy Serono SA for $13.3 billion, just five months after Europe's largest biotechnology company took down the for-sale sign.
The "Dietary Supplement and Nonprescription Drug Consumer Protection Act" will cost the federal government $3 million in 2007 and $50 million from 2007 to 2011 if it becomes law, the Congressional Budget Office (CBO) estimated Sept. 12.
More trouble is emerging for Merck over its painkiller Vioxx, as researchers say they have found "increased renal and arrhythmia risks" from the drug and have confirmed cardiovascular risks.
The Bush administration's nomination of Andrew von Eschenbach to be the next FDA commissioner is still facing a hold on the Senate floor even as the nomination passed out of committee Sept. 20 by a voice vote.
President Bush's choice to head the Food and Drug Administration won long-delayed approval from a key Senate committee on Wednesday, but the nominee still faces hurdles to winning confirmation from the full Senate.